Want to join the conversation?
Drug wholesale company $ABC reported a 2Q16 profit, helped by contributions from its acquisitions as well as from its specialty and consulting businesses. The company reported 2Q16 earnings of $604.14MM, or $2.68 per share, compared to a net loss of $513.39MM, or $2.33 per share a year ago. Revenue rose to $35.7Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?